Pluxee N.V.
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
17 disclosures on record
Evolution of the disclosed total
0%1%2%3%
2.17% 2024 0% today
20252026
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 29, 2026 | Citadel Advisors LLC | 0.49% | May 4, 2026 |
| April 9, 2026 | Citadel Advisors LLC | 0.50% | May 4, 2026 |
| May 15, 2025 | Marshall Wace LLP | 0.49% | May 19, 2025 |
| April 25, 2025 | Marshall Wace LLP | 0.52% | May 19, 2025 |
| April 17, 2025 | Marshall Wace LLP | 0.48% | April 25, 2025 |
| April 3, 2025 | Marshall Wace LLP | 0.59% | April 25, 2025 |
| March 21, 2025 | Marshall Wace LLP | 0.60% | April 25, 2025 |
| March 6, 2025 | Marshall Wace LLP | 0.50% | April 25, 2025 |
| February 13, 2024 | Greenvale Capital LLP | 0.33% | February 15, 2024 |
| February 7, 2024 | Millennium International Management LP | 0.29% | February 9, 2024 |
| February 6, 2024 | Greenvale Capital LLP | 0.78% | February 15, 2024 |
| February 6, 2024 | Millennium International Management LP | 0.61% | February 9, 2024 |
| February 5, 2024 | Millennium International Management LP | 0.85% | February 9, 2024 |
| February 5, 2024 | Citadel Securities GP LLC | 0.40% | February 7, 2024 |
| February 1, 2024 | Millennium International Management LP | 0.94% | February 9, 2024 |
| February 1, 2024 | Greenvale Capital LLP | 0.67% | February 15, 2024 |
| February 1, 2024 | Citadel Securities GP LLC | 0.56% | February 7, 2024 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.55% of the capital sold short
- Teleperformance 10.50% of the capital sold short
- Renault 6.88% of the capital sold short
- FDJ United 6.06% of the capital sold short
- Worldline 5.37% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Alstom 5.31% of the capital sold short
- Viridien 4.97% of the capital sold short
- Abivax 4.85% of the capital sold short
- Vusiongroup 4.76% of the capital sold short
- Forvia 4.63% of the capital sold short